トランスフェクション技術市場：製品、方法、技術、用途、エンドユーザー別-2025-2030年の世界予測

トランスフェクション技術市場は、2023年に12億2,000万米ドルと評価され、2024年には13億5,000万米ドルに達すると予測され、CAGR 9.97％で成長し、2030年には23億9,000万米ドルに達すると予測されています。

トランスフェクション技術には、真核細胞に核酸を導入し、遺伝子発現、遺伝子サイレンシング、ゲノム編集を促進するために使用されるさまざまな方法が含まれます。これらの技術の必要性は、創薬、遺伝子研究、治療開発における重要な役割にあり、分子生物学、遺伝学、生物医学研究における貴重なツールとなっています。用途は遺伝子発現研究、タンパク質生産、遺伝子治療開発など多岐にわたり、最終用途は製薬、学術研究機関、バイオテクノロジー企業です。主な成長要因としては、生体分子構造の進歩、遺伝子治療や細胞ベースの研究における資金調達の増加、合成生物学アプリケーションの需要増などが挙げられます。最近の潜在的なビジネスチャンスは、CRISPR技術の強化、非ウイルス性トランスフェクション法の開発、トランスフェクションが困難な細胞へのトランスフェクションにあり、企業が戦略的投資や共同研究を通じてターゲットとすべき新興国市場を示しています。しかしながら、高コスト、特定の試薬の細胞毒性、初代細胞やin vivo条件下での送達効率の悪さといった課題が、市場成長に大きな制約を与えています。知的財産の問題や厳しい規制の枠組みが、市場力学をさらに複雑にしています。イノベーションは、トランスフェクション効率の向上、細胞毒性の最小化、新規デリバリーベクターの開発、トランスフェクションの結果を予測し最適化するためのAIの統合に焦点を当てるべきです。さらに、生分解性ポリマーやナノテクノロジーに基づく送達システムの探求は、潜在的な成長の道を示しています。市場の競争は依然として激しく、支配的な企業が強い足場を築いているが、革新的なソリューションを備えた新規・新興企業が市場の重要なニッチを切り開く余地もあります。全体として、技術の進歩や規制の開発に合わせ、包括的な品質保証を採用し、エンドユーザー向けの教育やサポートサービスを強化することが、トランスフェクション技術市場の有望な成長軌道を活用する上で極めて重要です。

市場力学：急速に進化するトランスフェクション技術市場の主要市場インサイトを公開

トランスフェクション技術市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化医療とバイオ医薬品に対する需要の高まり
  • 新規の非ウイルス送達システムの開発と、商業的治療応用に向けたプロセスのスケールアップ
  • トランスフェクション技術における研究開発のための公的および民間資金の増加
• 市場抑制要因
  • 高度なトランスフェクション技術および関連製品の比較的高いコスト
• 市場機会
  • mRNAワクチンの開発が進んでいるため、大量生産が可能な強固なトランスフェクションシステムが必要とされている
  • 特定の細胞タイプや用途に合わせた、多用途でカスタマイズ可能なトランスフェクション試薬や装置の開発
• 市場の課題
  • 遺伝子治療製品とトランスフェクション技術に対する厳しい規制要件

ポーターのファイブフォース：トランスフェクション技術市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：トランスフェクション技術市場における外部からの影響の把握

外部マクロ環境要因は、トランスフェクション技術市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析トランスフェクション技術市場における競合情勢の把握

トランスフェクション技術市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックストランスフェクション技術市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、トランスフェクション技術市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨トランスフェクション技術市場における成功への道筋を描く

トランスフェクション技術市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 個別化医療とバイオ医薬品の需要の高まり
    • 新規の非ウイルス性送達システムの開発と商業治療への応用に向けたプロセスのスケールアップ
    • トランスフェクション技術における研究開発への公的資金と民間資金の増加
  • 抑制要因
    • 高度なトランスフェクション技術および関連製品のコストが比較的高い
  • 機会
    • mRNAワクチンの継続的な開発には、大規模生産のニーズに対応できる堅牢なトランスフェクションシステムが必要でした。
    • 特定の細胞タイプや用途に合わせた、多用途でカスタマイズ可能なトランスフェクション試薬および装置の開発
  • 課題
    • 遺伝子治療製品に対する厳格な規制要件とトランスフェクション技術
• 市場セグメンテーション分析
  • 方法：コスト効率による試薬ベースの方法の重要性の高まり
  • 用途：バイオ医薬品開発におけるタンパク質生産の多様な用途
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 トランスフェクション技術市場：製品別

• 機器
• 試薬とキット

第7章 トランスフェクション技術市場：方法別

• カチオン脂質トランスフェクション
• 共トランスフェクション
• エレクトロポレーション
• 生体内トランスフェクション
• リポフェクション
• ヌクレオフェクション

第8章 トランスフェクション技術市場：技術別

• 生化学に基づくトランスフェクション
• 物理的トランスフェクション
• ウイルスベクターベースのトランスフェクション

第9章 トランスフェクション技術市場：用途別

• バイオメディカル調査
• 遺伝子サイレンシング
• タンパク質生産
• 安定細胞株の生成
• 幹細胞の再プログラミングと分化
• 治療の実施
• ウイルスの生産

第10章 トランスフェクション技術市場：エンドユーザー別

• 学術調査機関
• 契約調査機関
• 製薬・バイオテクノロジー企業

第11章 南北アメリカのトランスフェクション技術市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域のトランスフェクション技術市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのトランスフェクション技術市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ポリプラス、新たなDOEサービスオプションを備えたFectoVIR-LVトランスフェクション試薬を発売
  • BioCentriqとKytopenが提携を拡大し、革新的な遺伝子編集技術が細胞治療製造に与える影響を加速
  • アヴェクタス、比類のない細胞の健康と機能性を備えた次世代の遺伝子組み換え細胞治療の臨床製造のためのソルポアプラットフォームを発表
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Akron Biotech
• Altogen Biosystems
• Bio-Rad Laboratories, Inc.
• Biomol GmbH
• Epoch Life Science
• F. Hoffmann-La Roche AG
• FUJIFILM Wako Pure Chemical Corporation
• Geno Technology, Inc.
• Lonza Group
• Maxcyte Inc.
• Merck KGaA
• Mirus Bio
• OriGene Technologies, Inc.
• OZ Biosciences SAS
• Polyplus-transfection SA by Sartorius AG
• Polysciences, Inc.
• Promega Corporation
• Qiagen NV
• Reprocell Inc.
• SignaGen Laboratories
• Takara Bio Inc.
• Thermo Fisher Scientific, Inc.
• VWR International, LLC by Avantor

LIST OF FIGURES

• FIGURE 1. TRANSFECTION TECHNOLOGIES MARKET RESEARCH PROCESS
• FIGURE 2. TRANSFECTION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSFECTION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSFECTION TECHNOLOGIES MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REAGENT & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CATIONIC LIPID TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COTRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY IN VIVO TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY LIPOFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY NUCLEOFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIOCHEMICAL BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHYSICAL TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRAL-VECTOR BASED TRANSFECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY BIO-MEDICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY GENE SILENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PROTEIN PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STABLE CELL LINE GENERATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STEM CELL REPROGRAMMING & DIFFERENTIATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY THERAPEUTIC DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY VIRUS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 51. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 52. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 53. CANADA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 65. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 71. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 78. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 79. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 80. CHINA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 83. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 85. INDIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 137. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 169. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 170. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 171. ITALY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 189. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 190. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 191. POLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 194. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 195. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 196. QATAR TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 197. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 202. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 207. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 212. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 217. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 227. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 237. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 242. TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 243. TRANSFECTION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

The Transfection Technologies Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.35 billion in 2024, and is projected to grow at a CAGR of 9.97%, to USD 2.39 billion by 2030.

Transfection technologies encompass a range of methods used to introduce nucleic acids into eukaryotic cells, facilitating gene expression, gene silencing, or genome editing. The necessity of these technologies lies in their critical role in drug discovery, genetic research, and therapeutic development, making them invaluable tools in molecular biology, genetics, and biomedical research. Applications span across gene expression studies, protein production, and development of gene therapies, with significant end-use in pharmaceuticals, academic research institutions, and biotechnology firms. Key growth influences include advancements in biomolecular structures, increased funding in gene therapy and cell-based research, and rising demand for synthetic biology applications. Recent potential opportunities lie in CRISPR technology enhancements, development of non-viral transfection methods, and transfection in difficult-to-transfect cells, representing emerging markets that companies should target through strategic investments and collaborations. However, challenges such as high costs, cytotoxicity of certain reagents, and delivery inefficiency in primary cells or in vivo conditions pose significant limitations to market growth. Intellectual property issues and stringent regulatory frameworks further complicate market dynamics. Innovation should focus on enhancing transfection efficiency, minimizing cytotoxicity, developing novel delivery vectors, and integrating AI to predict and optimize transfection outcomes. Additionally, exploring biodegradable polymers and nanotechnology-based delivery systems presents potential growth avenues. The market nature remains competitive with strong footholds of dominant players yet offers space for novel and emerging companies equipped with innovative solutions to carve out significant market niches. Overall, aligning with technological advancements and regulatory developments, adopting comprehensive quality assurance, and enhancing educational and support services for end users will be crucial in capitalizing on the promising growth trajectory of the transfection technologies market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transfection Technologies Market

The Transfection Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand for personalized medicine and biopharmaceuticals
  • Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
  • Increased public and private funding for research and development in transfection technologies
• Market Restraints
  • Relatively high cost of advanced transfection technologies and related products
• Market Opportunities
  • Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
  • Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
• Market Challenges
  • Stringent regulatory requirements for gene therapy products and transfection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Transfection Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transfection Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transfection Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transfection Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transfection Technologies Market

A detailed market share analysis in the Transfection Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transfection Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transfection Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transfection Technologies Market

A strategic analysis of the Transfection Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transfection Technologies Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Akron Biotech, Altogen Biosystems, Bio-Rad Laboratories, Inc., Biomol GmbH, Epoch Life Science, F. Hoffmann-La Roche AG, FUJIFILM Wako Pure Chemical Corporation, Geno Technology, Inc., Lonza Group, Maxcyte Inc., Merck KGaA, Mirus Bio, OriGene Technologies, Inc., OZ Biosciences SAS, Polyplus-transfection SA by Sartorius AG, Polysciences, Inc., Promega Corporation, Qiagen NV, Reprocell Inc., SignaGen Laboratories, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor.

Market Segmentation & Coverage

This research report categorizes the Transfection Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instrument and Reagent & Kits.
• Based on Method, market is studied across Cationic Lipid Transfection, Cotransfection, Electroporation, In Vivo Transfection, Lipofection, and Nucleofection.
• Based on Technology, market is studied across Biochemical Based Transfection, Physical Transfection, and Viral-Vector Based Transfection.
• Based on Applications, market is studied across Bio-Medical Research, Gene Silencing, Protein Production, Stable Cell Line Generation, Stem Cell Reprogramming & Differentiation, Therapeutic Delivery, and Virus Production.
• Based on End-user, market is studied across Academic & Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for personalized medicine and biopharmaceuticals
    • 5.1.1.2. Development of novel, non-viral delivery systems and scaling up processes for commercial therapeutic applications
    • 5.1.1.3. Increased public and private funding for research and development in transfection technologies
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of advanced transfection technologies and related products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing development of mRNA vaccines necessitated robust transfection systems capable for large-scale production needs
    • 5.1.3.2. Development of versatile and customizable transfection reagents and equipment tailored for specific cell types and applications
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for gene therapy products and transfection technologies
• 5.2. Market Segmentation Analysis
  • 5.2.1. Method: Rising significance of reagent-based methods due to cost effectiveness
  • 5.2.2. Application: Diverse applications in protein production in biopharmaceutical development
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Transfection Technologies Market, by Product

• 6.1. Introduction
• 6.2. Instrument
• 6.3. Reagent & Kits

7. Transfection Technologies Market, by Method

• 7.1. Introduction
• 7.2. Cationic Lipid Transfection
• 7.3. Cotransfection
• 7.4. Electroporation
• 7.5. In Vivo Transfection
• 7.6. Lipofection
• 7.7. Nucleofection

8. Transfection Technologies Market, by Technology

• 8.1. Introduction
• 8.2. Biochemical Based Transfection
• 8.3. Physical Transfection
• 8.4. Viral-Vector Based Transfection

9. Transfection Technologies Market, by Applications

• 9.1. Introduction
• 9.2. Bio-Medical Research
• 9.3. Gene Silencing
• 9.4. Protein Production
• 9.5. Stable Cell Line Generation
• 9.6. Stem Cell Reprogramming & Differentiation
• 9.7. Therapeutic Delivery
• 9.8. Virus Production

10. Transfection Technologies Market, by End-user

• 10.1. Introduction
• 10.2. Academic & Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Transfection Technologies Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Transfection Technologies Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Transfection Technologies Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Polyplus Launches FectoVIR-LV Transfection Reagent with New DOE Service Options
  • 14.3.2. BioCentriq and Kytopen Expand Partnership to Expedite Impact of Transformative Gene-Editing Technology on Cell Therapy Manufacturing
  • 14.3.3. Avectas Launches the Solupore Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Akron Biotech
• 3. Altogen Biosystems
• 4. Bio-Rad Laboratories, Inc.
• 5. Biomol GmbH
• 6. Epoch Life Science
• 7. F. Hoffmann-La Roche AG
• 8. FUJIFILM Wako Pure Chemical Corporation
• 9. Geno Technology, Inc.
• 10. Lonza Group
• 11. Maxcyte Inc.
• 12. Merck KGaA
• 13. Mirus Bio
• 14. OriGene Technologies, Inc.
• 15. OZ Biosciences SAS
• 16. Polyplus-transfection SA by Sartorius AG
• 17. Polysciences, Inc.
• 18. Promega Corporation
• 19. Qiagen NV
• 20. Reprocell Inc.
• 21. SignaGen Laboratories
• 22. Takara Bio Inc.
• 23. Thermo Fisher Scientific, Inc.
• 24. VWR International, LLC by Avantor